Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Reexamination Certificate
2007-09-11
2007-09-11
Coleman, Brenda (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
C540S542000
Reexamination Certificate
active
11244599
ABSTRACT:
Compounds of formula (I) or pharmaceutically acceptable salts thereof are provided:wherein:A is alkylenyl of 1 to 4 carbon atoms, or alkenylenyl of 2 to 4 carbon atoms;R1and R2are, independently, hydrogen or a C5to C7aryl optionally substituted with 1 to 2 substituents, independently, selected from the group consisting of —C(O)R3, halogen, cyano, nitro, hydroxyl, C1-C6alkyl, and C1-C6alkoxy,with the proviso that at least one of R1and R2is not hydrogen;R3is, independently, hydrogen, —OR4, alkyl, aryl, or heteroaryl;R4is hydrogen, alkyl, aryl, or heteroaryl;R5and R6are, independently, hydrogen, alkyl, hydroxyl, alkoxy, or C5to C7aryl;wherein any R3to R6group having an aryl or heteroaryl moiety can optionally be substituted on the aryl or heteroaryl moiety with 1 to about 5 substituents, independently, selected from the group consisting of halogen, cyano, nitro, hydroxyl, C1-C6alkyl, and C1-C6alkoxy.Methods of making these compounds as well as methods using the compounds for treating a variety of conditions are also disclosed.
REFERENCES:
patent: 5168103 (1992-12-01), Kinney et al.
patent: 2005/0004080 (2005-01-01), Baudy et al.
patent: 0 496 561 (1992-07-01), None
patent: 0 496 561 (1992-07-01), None
patent: 0 496 561 (1995-03-01), None
Brown et al., N-Methyl-D- Aspartate Receptor (NMDA) Antagonists as Potential Pain Therapeutics, Current Topics in Medicinal Chemistry, vol. 6, No. 8, pp. 749-770, 2006.
Brandt, M. R. et al. “Antinociceptive Effects of δ-Opioid Agonsists in Rhesus Monkeys: Effects on Chemically Induced Thermal Hypersensitivity,”J. Pharmacol. Exper. Ther., 2001, 296, 939-946.
Diagnostic and Statistical Manual of Mental Disorders, 4th edition, Washington, DC, American Psychiatric Association (1994), pp. 273-315, 317-391 and 393-445.
Eliel, E. L.,Stereochemistry of Carbon Compounds, McGraw Hill, NY (1962) Ch. 4, pp. 46-87.
Jacques, J. et al.,Enantiomers, Racemates and Resolutions, Wiley Interscience, NY (1981) pp. 251-434.
Mendell, J. R. et al., “Painful Sensory Neuropathy,”N. Engl. J. Med., Mar. 27, 2003, 348(13), pp. 1243-1255.
Physicians' Desk Reference, 55th Edition, 2001, published by Medical Economics Co., Inc., Montvale, NJ, Section 3, pp. 201-216.
Remington's Pharmaceutical Sciences, 17thEd., Gennaro, A. R. (Ed.), Mack Publishing Company, Easton, PA (1985) pp. 1409-1677.
Wilen, S.H.,Tables of Resolving Agents and Optical Resolutions, pp. 268-298, E.L. Eliel, Ed., University of Notre Dame Press, Notre Dame, IN 1972.
Wilen, S.H., et al., “Strategies in optical resolutions,”Tetrahedron, 33, pp. 2725-2736, 1977.
Coleman Brenda
Woodcock & Washburn LLP
Wyeth
LandOfFree
Derivatives of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Derivatives of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Derivatives of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3755187